After-Hours Stock Movers 09/22: (NKE) (FL) (TSLA) Higher; (WVE) (SFIX) (ACB) Lower (more...)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- Wall St slips as Gulf tensions send oil to over six-week high
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Citi initiates UiPath coverage with Buy rating and $23 target
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- Trump says Canada's Bombardier must build jets in US or lose market access
- European shares subdued as surging crude sharpens focus on ECB rate path
- Wall St slips as Gulf tensions send oil to over six-week high
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Stitch Fix, Inc. (SFIX) PT Lowered to $34 at Needham & Company
September 23, 2020 7:24 AM EDTNeedham & Company analyst Rick Patel lowered the price target on Stitch Fix, Inc. (NASDAQ: SFIX) to $34.00 (from $36.00) while maintaining a Buy rating following 4Q earnings report and guidance. SFIX reported F4Q revenues +2.6%, better than the Street estimate of (3.9%). Adjusted EBITDA was $12.1m,... More
RBC Capital Reiterates Underperform Rating on Tesla (TSLA) Following Battery Day
September 23, 2020 7:16 AM EDTRBC Capital analyst Joseph Spak reiterated an Underperform rating and $290.00 price target on Tesla (NASDAQ: TSLA) following the company's battery day. Overall, Spak believes Teslas long-awaited battery day disappointed elevated expectations, as it highlighted some near-term stagnation in the price reduction of current... More
WAVE Life Sciences (WVE) Prices 8.33M Share Offering at $12/Sh
September 23, 2020 7:03 AM EDTWave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today the pricing of its previously announced underwritten public offering of 8,333,334 of its ordinary shares at a price to the public of... More
